Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naive advanced non-small cell lung cancer Article Proceedings Paper

Industry Collaboration International Collaboration

cited authors

  • Langer, Corey J.; O'Byrne, Kenneth J.; Socinski, Mark A.; Mikhailov, Sergei M.; Lesniewski-Kmak, Krzysztof; Smakal, Martin; Ciuleanu, Tudor E.; Orlov, Sergey V.; Dediu, Mircea; Heigener, David; Eisenfeld, Amy J.; Sandalic, Larissa; Oldham, Fred B.; Singer, Jack W.; Ross, Helen J.

authors

Publication Date

  • June 1, 2008

webpage

published in

category

keywords

  • CT-2103
  • PPX
  • PS 2
  • non-small cell lung cancer
  • paclitaxel poliglumex
  • toxicity

start page

  • 623

end page

  • 630

volume

  • 3

issue

  • 6